Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics

The Mount Sinai Division of Pediatric Endocrinology and Diabetes participates in basic and clinical research projects in endocrinology and diabetes. These include a JDRF-funded study of HLA-DR/Peptide Chimeras to Arrest Type 1 Diabetes (S. Casares, PI), a national study of the effects of Human Growth Hormone in children born small for gestational age (R. Rapaport, National PI), and numerous other national clinical trials of growth and growth hormone therapy.

• Genetics and Neuroendocrinology Short Stature International Study (GeNeSIS) Core Study

  Substudies

  • Growth Prediction
  • DNA Analysis
  • SHOX Deficiency
  • Neoplasia
  • Idiopathic Short Stature
• Global Hypopituitary Control and Complications Study (HypoCCs II)
• Small for Gestational Age Pharmacogenetics Trial
• Arimidex Study Double-blind Trial investigating the Safety and Efficacy of the Aromatase Inihibitor Anastrozole
• Efficacy and Safety of Insulin Glulisine compared with insulin lispro in children and adolescents with type 1 diabetes mellitus
  A 26-week, multicenter, open, parallel clinical trial

Back to Departmental Research